GlobeNewswire

DNAtix, the Genetics Blockchain Company, Introduces Complete Genome Sequencing Pilot and Announces Token Sale

Del

Anonymous DNA Testing, Transfer, Storage with Total Control of Personal Data

 

AMSTERDAM, Netherlands, June 27, 2018 (GLOBE NEWSWIRE) -- Digital DNAtix Ltd., the genetics blockchain company, today announced the pilot of a breakthrough blockchain-based infrastructure and ecosystem for anonymous genetic testing, services and research. DNAtix is the first company to successfully transfer a genetic sequence over the Ethereum Blockchain. The DNAtix genetics ecosystem links individual users in the search of health solutions, or answers to ancestral questions, with products and services that fit their needs. DNAtix is also developing a dedicated Token - the DNATIX token - that will be integrated into the use of its DNAtix genetic platform.

"DNAtix is solving the privacy issue once and for all for testing highly sensitive DNA data with the first infrastructure blockchain ecosystem solution for anonymous genetic services," said Ofer A. Lidsky the CEO & CTO of the DNAtix. "Consumers, healthcare institutions, research centers, clinics, genetic counselors and others interested in using, testing, or gathering DNA data can now connect, work together for better health solutions and feel confident in sharing their genetic information."

Anyone can anonymously upload partial and/or full genome sequences onto the DNAtix platform; contributors own their genomic data and use it to make informed decisions.

Technology Breakthrough: An entire genetics ecosystem on the blockchain
Opening the door for advancements in research, new treatments, and cutting-edge personalized and preventive medicine, DNAtix's D2C platform provides full genome testing and access to services and solutions on the Blockchain and allows researchers to use anonymous DNA, stored on the DNAtix infrastructure, to create tests, do research and design new treatments.

In order to better leverage the emerging infrastructure and potential of blockchain genetic storage, DNAtix has developed and freely releases its compression algorithm for the mutual betterment of the field; Thus far, DNA storage efficiency has been increased by 300%.
GitHub repository: https://github.com/DNAtix/DNAtix-DNA-Compression-Tool

The DNATIX Token
DNAtix is in the private sale stage of its token to fund the delivery of anonymous genetic services at an affordable price point. The DNAtix token has smart contracts built into it enabling -for the first time- the anonymous and secure analysis, transfer, and storage of DNA sequences. The DNAtix wallet will facilitate anonymous payment for a wide range of genetic services. For more information and purchase instructions about DNAtix token sale, email:  info@dnatix.com.

SPEAKING: DNAtix AT BLOCKCHAIN EXPO EUROPE  
Ofer A. Lidsky will be presenting twice at Blockchain Expo Europe:

· Track:  Developing Blockchain Applications
· Day/Time:  Day 1 (27 June) 14:40 - 14:50
· Title: Introducing new developments 2 (When Blockchain Meets Genetics)
   
· Track: Blockchain Technologies
· Day/Time: Day 2 (28 June) 09:40 - 10:20
· Keynote Panel: What does the future hold for Blockchain technology - where do we think we will be in 2030?

More information: https://blockchain-expo.com/europe/speaker/senior-representative-dnatix/

ABOUT DNAtix
DNAtix, a cutting-edge genetics and blockchain company, is building the infrastructure for the world's genetic blockchain ecosystem where researchers, hospitals, developers, clinicians and others will develop next generation, decentralized genetics applications and health management solutions. DNAtix is also delivering a direct-to-consumer platform that offers anonymous and encrypted genome sequencing and genetic services, including digitized DNA analysis, storage and transfer.  The DNAtix genetics ecosystem is a place where consumers and the industry can meet to share genetic data in a more transparent, accessible, applicable and secured manner. DNAtix is developing the future ecosystem for Genetics which is Blockchain based and includes cutting edge new innovative ideas and technologies. With a first successful proof of concept already completed for transferring a DNA sequence over the Ethereum blockchain DNAtix is leading the world of Genetic blockchain.  www.dnatix.com 

Media Contact: 
Heidi Groshelle 
Groshelle Communications 
heidi@groshelle.com 
415.307.1380

A video accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9f9e2aca-e48d-4d99-a20f-860e3995878b 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DNAtix via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Bio-Fence announces a breakthrough in Food Safety18.1.2019 08:11Pressemelding

The company have successfully completed a field trial of its new anti-microbial coating technology. The trials demonstrated a significant reduction in bacterial contamination during sensitive food production processes ASHDOD, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Bio-Fence innovating coating technology announced today the successful completion of an intensive field trial on its innovative anti-microbial technology Pentagon. The trial was held in "Milouoff" (http://www.milouoff.co.il), one of the largest Ready to Eat poultry production sites in Israel and demonstrated superior results for Bio-Fence technology compared to alternatives. According to Mrs. Shiran Davidi, QA manager at Milouoff: “Bio-Fence technology seems to have clear benefits over existing antimicrobial solution. It is safe, highly potent and rechargeable.” The trial involved monitoring the performance of an epoxy floor coated with Bio-Fence anti-microbial technology compared to either commercial Silver Ion coating an

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting18.1.2019 07:00Pressemelding

LYON, France and CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced that a poster entitled “TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)” will be presented today at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in San Francisco. The poster (Abstract # TPS471) will be available at www.erytech.com after presentation at the conference. In September 2018, the TRYbeCA-1 trial was initiated. The Trial-in-Progress poster will provide an update on the study progress with investigators sites that have been initiated in multiple countries and actively recruiting patients. The trial is planned to enroll approximately 500 patients with

Fossil Group Enters Agreement To Sell Select Smartwatch Technology To Google17.1.2019 18:30Pressemelding

Transaction Unlocks Growth Opportunities for Fossil Group’s Wearables Business RICHARDSON, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Today, Fossil Group (NASDAQ:FOSL) announced its plan to sell to Google for $40 million intellectual property (IP) related to a smartwatch technology currently under development by Fossil Group. As part of the transaction, a portion of Fossil Group’s research and development (R&D) team currently supporting the transferring IP will join Google. Fossil Group retains more than 200 R&D team members to focus on innovation and product development. The transaction showcases Fossil Group and Google’s shared investment in the wearables industry. In recent years, smartwatches have become Fossil Group’s fastest growing category. The company successfully developed and launched smartwatches across 14 of its owned and licensed brands. “Fossil Group has experienced significant success in its wearables business by focusing on product design and development informed by our

Calgon Carbon Corporation Announces Global Price Increase17.1.2019 17:16Pressemelding

Pittsburgh, PA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Calgon Carbon Corporation today announced a global price increase, effective February 1, 2019, where contracts permit, on all activated carbon products and related equipment due to a continued escalation in raw material costs and transportation expenses. The increase is expected to range between 10-15%, depending on the specific product, raw material type, services provided, and global market dynamics. The primary raw materials used for producing activated carbon are coal, coconut shell, and wood, each of which has gone up in price. Additionally, costs associated with both operating manufacturing facilities and transporting materials have also escalated. “Calgon Carbon’s raw material costs have increased significantly. Despite every effort to offset these increases through continuous improvements, the recent rise in raw material costs has exceeded our efforts,” said Jim Coccagno, Chief Commercial Officer for Calgon Carbon Corporation. “

Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station17.1.2019 15:29Pressemelding

RENSSELAER, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight missions with NASA since 1985. Most recently, as part of the science and research investigation payloads supported by the SpaceX Commercial Resupply Services missions, Taconic prepared mice to live aboard the International Space Station for extended periods. Previous spaceflight studies demonstrated that mice undergo rapid loss of muscle and bone mass, resembling accelerated aging. Therefore, mice exposed to microgravity via spaceflight are a valuable model to understand and devel

MPP Global Bridges the Innovation Gap by Centralising Physical and Digital Subscriber Management and Billing in a Single Cloud Platform17.1.2019 12:29Pressemelding

WARRINGTON, UK, Jan. 17, 2019 (GLOBE NEWSWIRE) -- MPP Global, the technology company that delivers eSuite, the world’s smartest subscriber management & billing platform, announces the launch of pivotal new functionality which enables media organisations to seamlessly create and manage the sale of physical subscriptions. This positions eSuite as the complete physical and digital subscription management solution. The development of this industry-first functionality was borne out of the common challenge for publishers when managing multiple systems for deploying bundled print and digital subscriptions. This is inflexible for publishers and limits choice for their customers, restricting the ability to seamlessly create and offer digital and print subscription bundles. Despite increased consumer uptake of digital subscriptions, print still accounts for almost 90% of circulation revenues globally. To drive reader revenues successfully, publishers require functionality to execute complementar